International Journal Open Access

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Authors

Writing Group for the Women's Health Initiative Investigators

Journal

JAMA

Year Published

2002

Publisher

American Medical Association

Citations

15877 citations

Type

Article

Language

EN

Topics & Concepts

Medicine (0.95) Women's Health Initiative (0.83) Medroxyprogesterone acetate (0.70) Hazard ratio (0.61) Randomized controlled trial (0.52)

Abstract

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial - Full text available via OpenAlex

Author Details

Writing Group for the Women's Health Initiative Investigators

Data provided by OpenAlex - An open catalog of the world's scholarly papers, researchers, and institutions

Join our WhatsApp Channel